background image

Incyte Clinical Trials

Find clinical trials for Incyte. Search for Incyte clinical trials in different cities and states across the United States.

Filter
New

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

for
Myeloproliferative Neoplasms
Location: Columbus OH, Atlanta GA, Nashville TN
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07441694

Phase1, Recruiting
New

A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia

for
Essential Thrombocythemia
Location: Greenbrae CA
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07623200

Phase3, Recruiting

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

for
Myeloproliferative Neoplasms
Location: Boston MA, New York NY, Baltimore MD, Miami FL,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT06034002

Phase1, Recruiting

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

for
Ovarian Cancer
Location: Winston-Salem NC, Charlotte NC, Chattanooga TN,
Sponsor: Incyte Corporation

Sex: Female

Age: 18+

Code: NCT07214779

Phase3, Recruiting

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

for
Solid Tumors, Hematologic Malignancies
Location: Nashville TN, Omaha NE, Houston TX, Duarte CA
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07195916

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors

for
Solid Tumors, Advanced Solid Tumors, Metastatic Solid Tumors
Location: Boston MA, Providence RI, Mineola NY, New York NY,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT05836324

Phase1, Recruiting

A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)

for
Graft-versus-host Disease (GVHD)
Location: Boston MA, New York NY, Philadelphia PA, Richmond VA,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT06615050

Phase3, Recruiting

Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population

for
Pregnancy Related, Atopic Dermatitis
Location: Morrisville NC
Sponsor: Incyte Corporation

Sex: Female

Age: 15 - 50

Code: NCT06259669

Recruiting

A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

for
Chronic Graft-versus-host-disease
Location: Halifax, Boston MA, Stony Brook NY, Hackensack NJ,
Sponsor: Incyte Corporation

Sex: All

Age: 12+

Code: NCT06585774

Phase3, Recruiting

An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis

for
Pregnancy Related, Atopic Dermatitis
Location: Morrisville NC
Sponsor: Incyte Corporation

Sex: Female

Age: 14+

Code: NCT06627335

Recruiting